Work

Erratum to “The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs” [European Journal of Pharmaceutical Sciences (2025) 107337]

Year: 2025

Type: erratum

Source: European Journal of Pharmaceutical Sciences

DOI: 10.1016/j.ejps.2025.107384

Authors: Yen-Ching Li, Bing-Huan Lin, Megumi Murakami, Yu-Shan Wu, Tai-Ho Hung, Suresh. V. Ambudkar, Chung-Pu Wu

Institutions: Chang Gung University, National Cancer Institute, Center for Cancer Research, Tunghai University, Chang Gung Memorial Hospital, Keelung Chang Gung Memorial Hospital, National Institutes of Health

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,070

OpenAlex ID: W4417008223

Cites:

Cited by:

Related to: